He also went on to give a summary of last year, stating that “initially we were faced with a shortage of PPE equipment, ventilators and N-95 masks,” but soon shifted focus to India’s triumphs in treating the virus. He stated that “we were able to export these things to different …
Read More »Confident that the Covid-19 vaccine will be ready in three to four months: Dr. Harsh Vardhan | India News
NEW DELHI: The Union Minister of Health and Family Welfare, Dr. Harsh Vardhan, said Thursday that he was confident that the Covid-19 vaccine would be ready in the next three to four months, adding that the priority of providing the same to the Indians 135 crore would be based on …
Read More »Oxford covid vaccine produces promising response in older adults in initial study
The University of Oxford confirmed that the Covid-19 vaccine it is developing with AstraZeneca Plc produced strong immune responses in older adults in a preliminary study, and key findings from the final phase of trials are expected in the coming weeks. The results, published Thursday in the medical journal The …
Read More »Covid-19 Cases Latest News, Covid-19 Vaccine Tracker, Delhi Lockdown Today News Update
A female passenger, dressed in a protective suit, waits for the train at the New Delhi train station (Express Photo: Amit Mehra) Kashmir seroprevalence survey: Kashmir’s first seroprevalence survey has revealed that close to 40 percent of people in the Valley have developed antibodies to Covid-19. The survey, which analyzed …
Read More »Covaxin Coronavirus Vaccine Update: First and Largest Phase 3 Human Trials of Covid-19 Vaccine Begin in India
Coronavirus Vaccine in India: Bharat Biotech, together with the Indian Council for Medical Research (ICMR) and the National Institute of Virology (NIV), is developing the indigenous coronavirus vaccine Covaxin. Coronavirus vaccine in India: Phase 3 human trials of the indigenous experimental vaccine Covaxin, a candidate for the coronavirus vaccine, are …
Read More »Covid-19 Vaccine: 5 Things You Should Know About Pfizer’s Encouraging Trial Results
Pfizer Inc. and BioNTech SE announced Wednesday that the final efficacy analysis of their vaccine candidate, BNT162b2, undergoing the phase 3 trial met all of the study’s primary efficacy endpoints. Biotech companies said the study indicated a 95 percent vaccine efficacy rate, close to the efficacy rate found in early …
Read More »Pfizer and the BioNTech plan requesting authorization as the Covid-19 vaccine demonstrates 95% effectiveness
Pfizer Inc. said a final analysis of data from clinical trials showed that its Covid-19 vaccine was 95% effective, paving the way for the company to apply for the first U.S. regulatory clearance for a vaccine against the coronavirus in a few days. US drugmaker and partner BioNTech SE said …
Read More »Frontline workers, elderly likely on government priority list for Covid-19 vaccine administration
India’s priority list of people identified to receive the coronavirus disease (Covid-19) vaccine, when available for use, is likely to include people aged 65 and over, according to government sources. “Based on the discussions, the administration of the vaccine is likely to be done in phases with high-risk population groups …
Read More »Covid-19 Cases in India Latest News, Covid-19 Vaccine Tracker Today News Update
Testing for Covid-19 underway in Mumbai. (Express photo: Amit Chakravarty) * Delhi Covid-19 situation: 75 doctors, 250 paramedics from paramilitary forces en route to Delhi At least 75 doctors and 250 paramedics from the paramilitary forces are on their way from different parts of the country to serve the people …
Read More »Bharat Biotech launches massive phase 3 trial with 26,000 Covaxin participants
NEW DELHI: Bharat Biotech International Ltd has started massive phase 3 clinical trials of its covid-19 ‘Covaxin’ vaccine. The company plans to enroll 26,000 participants in total, making it the first phase 3 efficacy study for a COVID-19 vaccine and the largest efficacy trial ever conducted in India. As part …
Read More »